Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1508 Articles

Paul Ausick | May 6, 2014 at 11:05 AM EDT

Cross-Border Premium Implications in Merck-Bayer Transaction

Merck has had its consumer products business on the market since the beginning of this year, and Tuesday it announced…

Paul Ausick | May 5, 2014 at 4:01 PM EDT

The 4 Stocks That Moved the Markets

thinkstockMay 5, 2014: Markets opened lower on Monday but gamely pushed to the upside in midafternoon. General concern over the…

Paul Ausick | May 5, 2014 at 8:00 AM EDT

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

Drug giant Pfizer reported better-than-expected first-quarter 2014 earnings before markets opened Monday morning, but revenues fell short. Shares traded lower…

Jon C. Ogg | May 4, 2014 at 10:32 AM EDT

The Top Eight Earnings for the Week Ahead

Jon OggEarnings season is far from over, but roughly three quarters of the stocks in the Standard & Poor’s 500 Index…

Paul Ausick | May 2, 2014 at 8:55 AM EDT

AstraZeneca Declares Pfizer Bid ‘Inadequate’

British drug maker AstraZeneca once again rejected a takeover bid from U.S. pharmaceutical giant Pfizer, this one worth $106 billion…

Paul Ausick | Apr 28, 2014 at 4:01 PM EDT

The 4 Stocks That Led Markets Higher

thinkstockApril 28, 2014: Markets opened higher on Monday with little economic data to drive the market either up or down.…

cgblaine22 | Apr 26, 2014 at 8:30 AM EDT

Biotech: The Poster Child for Market Volatility in 2014

The NYSE Arca Biotechnology Index fell nearly 9% between a peak on Jan. 22 and a low on Feb. 5.…

Jon C. Ogg | Apr 23, 2014 at 8:50 AM EDT

UBS Top Stocks to Buy Working for Cancer Cures

In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are…

Paul Ausick | Apr 21, 2014 at 4:40 PM EDT

The 4 Stocks That Boosted Markets

thinkstockApril 21 2014: Markets opened higher on Monday but there wasn’t a lot of action as the only data out…

Jon C. Ogg | Apr 21, 2014 at 1:25 PM EDT

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

ThinkstockIt is not that common that you hear about mergers in the $50 billion range. But what about when you…

Jon C. Ogg | Apr 16, 2014 at 10:40 AM EDT

Why Lpath Could Rise 300%

Canaccord Genuity is one of the few firms that are willing to cover small-cap biotech and emerging pharma stocks. Sometimes…

Paul Ausick | Apr 7, 2014 at 4:27 PM EDT

The 4 Stocks That Slammed the Market

thinkstockApril 7, 2014: Markets opened lower on Monday and were on a downhill slide all day long. Momentum stocks again…

Jon C. Ogg | Apr 7, 2014 at 11:00 AM EDT

FDA Keeps Driving Up Future Cost of Inhalable Insulin

While the FDA has been far from a friend to MannKind over the past few years, the latest FDA panel…

Paul Ausick | Apr 1, 2014 at 7:50 AM EDT

U.S. Companies Park $947 Billion Offshore

ThinkstockWhen the S&P 500 index rises more than 25% in a year, you have to figure that some of the…

Paul Ausick | Mar 26, 2014 at 9:05 AM EDT

Telecoms Liven Up Short Interest in Big Dividend Stocks

ThinkstockThe short interest data for the first two weeks of March is out, and the results among the top high-yield…

1 … 67 68 69 70 71 … 101

Pfizer : PFE

All Pfizer Articles

Cross-Border Premium Implications in Merck-Bayer Transaction

The 4 Stocks That Moved the Markets

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

The Top Eight Earnings for the Week Ahead

AstraZeneca Declares Pfizer Bid ‘Inadequate’

The 4 Stocks That Led Markets Higher

Biotech: The Poster Child for Market Volatility in 2014

UBS Top Stocks to Buy Working for Cancer Cures

The 4 Stocks That Boosted Markets

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

Why Lpath Could Rise 300%

The 4 Stocks That Slammed the Market

FDA Keeps Driving Up Future Cost of Inhalable Insulin

U.S. Companies Park $947 Billion Offshore

Telecoms Liven Up Short Interest in Big Dividend Stocks

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Pfizer : PFE

All Pfizer Articles

Cross-Border Premium Implications in Merck-Bayer Transaction

The 4 Stocks That Moved the Markets

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

The Top Eight Earnings for the Week Ahead

AstraZeneca Declares Pfizer Bid ‘Inadequate’

The 4 Stocks That Led Markets Higher

Biotech: The Poster Child for Market Volatility in 2014

UBS Top Stocks to Buy Working for Cancer Cures

The 4 Stocks That Boosted Markets

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

Why Lpath Could Rise 300%

The 4 Stocks That Slammed the Market

FDA Keeps Driving Up Future Cost of Inhalable Insulin

U.S. Companies Park $947 Billion Offshore

Telecoms Liven Up Short Interest in Big Dividend Stocks

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Featured Reads

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It